000 | 01747 a2200505 4500 | ||
---|---|---|---|
005 | 20250517041256.0 | ||
264 | 0 | _c20160804 | |
008 | 201608s 0 0 eng d | ||
022 | _a2045-2322 | ||
024 | 7 |
_a10.1038/srep12007 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMoilanen, Anu-Maarit | |
245 | 0 | 0 |
_aDiscovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapies. _h[electronic resource] |
260 |
_bScientific reports _cJul 2015 |
||
300 |
_a12007 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAndrogen Receptor Antagonists _xpharmacology |
650 | 0 | 4 |
_aAndrogens _xphysiology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacokinetics |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aDrug Resistance, Neoplasm |
650 | 0 | 4 | _aHEK293 Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 | _aMice, Nude |
650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aPyrazoles _xpharmacokinetics |
650 | 0 | 4 |
_aReceptors, Androgen _xmetabolism |
650 | 0 | 4 | _aSignal Transduction |
650 | 0 | 4 |
_aTumor Burden _xdrug effects |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aRiikonen, Reetta | |
700 | 1 | _aOksala, Riikka | |
700 | 1 | _aRavanti, Laura | |
700 | 1 | _aAho, Eija | |
700 | 1 | _aWohlfahrt, Gerd | |
700 | 1 | _aNykänen, Pirjo S | |
700 | 1 | _aTörmäkangas, Olli P | |
700 | 1 | _aPalvimo, Jorma J | |
700 | 1 | _aKallio, Pekka J | |
773 | 0 |
_tScientific reports _gvol. 5 _gp. 12007 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/srep12007 _zAvailable from publisher's website |
999 |
_c25040258 _d25040258 |